These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3085873)

  • 1. Stimulation by gastrin-releasing peptide, neurotensin and DN1417, a novel TRH analog, of dopamine and norepinephrine release from perifused rat hypothalamic fragments in vitro.
    Kabayama Y; Kato Y; Shimatsu A; Yanaihara N; Imura H
    Brain Res; 1986 May; 372(2):394-9. PubMed ID: 3085873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraventricular administration of thyrotrophin-releasing hormone (TRH) suppresses prolactin secretion and synthesis: a possible involvement of dopamine release by TRH from rat hypothalamus.
    Ikegami H; Jikihara H; Koike K; Morishige K; Kurachi H; Yamamoto N; Hirota K; Miyake A; Tanizawa O
    J Endocrinol; 1992 Apr; 133(1):59-66. PubMed ID: 1355520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
    Narumi S; Nagai Y; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine- and amphetamine-regulated transcript peptide-(55-102) and thyrotropin releasing hormone inhibit hypothalamic dopamine release.
    Brunetti L; Orlando G; Michelotto B; Recinella L; Vacca M
    Eur J Pharmacol; 2000 Dec; 409(2):103-7. PubMed ID: 11104823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of opioid peptides and potassium on the release of vasoactive intestinal polypeptide and thyrotropin releasing hormone from perifused rat hypothalami.
    Burns G; Baker DJ; Brown BL; Dobson PR
    Life Sci; 1987 Mar; 40(10):951-7. PubMed ID: 3102870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin perfused in hypothalamus of sated or fasted rat: HPLC analysis of release of DA, NE and 5-HT and their metabolites.
    Miñano FJ; Peinado JM; Myers RD
    Peptides; 1988; 9(6):1381-7. PubMed ID: 3247254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence that central neurotensin inhibits pituitary prolactin secretion by stimulating dopamine release from the hypothalamus.
    Tojo K; Kato Y; Kabayama Y; Ohta H; Inoue T; Imura H
    Proc Soc Exp Biol Med; 1986 Apr; 181(4):517-22. PubMed ID: 3485291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyrotropin-releasing hormone (TRH): action mechanism of an enhanced dopamine release from rat striatal slices (author's transl)].
    Narumi S; Nagai Y; Nagawa Y
    Nihon Yakurigaku Zasshi; 1979 Apr; 75(3):239-50. PubMed ID: 119692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dynamics of arachidonic acid liberation and prolactin release: a comparison of thyrotropin-releasing hormone, angiotensin II, and neurotensin stimulation in perifused rat anterior pituitary cells.
    Ross PC; Judd AM; MacLeod RM
    Endocrinology; 1988 Nov; 123(5):2445-53. PubMed ID: 3139397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galanin stimulates the release of vasoactive intestinal polypeptide from perifused hypothalamic fragments in vitro and from periventricular structures into the cerebrospinal fluid in vivo in the rat.
    Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
    Neurosci Lett; 1988 Feb; 85(1):95-100. PubMed ID: 2452388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin augmentation of dopamine and norepinephrine release from superfused medial basal hypothalamic fragments.
    Foreman MM; Porter JC
    Endocrinology; 1981 Mar; 108(3):800-4. PubMed ID: 7460842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin regulation of TSH secretion in the rat.
    Sheppard MC; Askew RD; Shennan KI; Franks S; Ramsden DB
    Biochem Biophys Res Commun; 1983 May; 113(1):248-54. PubMed ID: 6407480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417.
    Narumi S; Nagai Y; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin perfusion of rat hypothalamus: dissociation of dopamine release from body temperature change.
    Myers RD; Lee TF
    Neuroscience; 1984 May; 12(1):241-53. PubMed ID: 6462447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of pro-thyrotropin-releasing hormone connecting peptides PS4 and PS5 from perifused rat hypothalamic slices.
    Valentijn K; Bunel DT; Liao N; Pelletier G; Vaudry H
    Neuroscience; 1991; 44(1):223-33. PubMed ID: 1722891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central effects of DN1417, a novel TRH analog, on plasma glucose and catecholamines in conscious rats.
    Kabayama Y; Kato Y; Tojo K; Shimatsu A; Ohta H; Imura H
    Life Sci; 1985 Apr; 36(13):1287-94. PubMed ID: 2858799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intrathecal administration of thyrotropin releasing hormone and its analogue, DN1417, on plasma glucose and catecholamine levels in conscious rats.
    Ishikawa Y; Shimatsu A; Kato Y; Murakami Y; Imura H
    Brain Res; 1990 Apr; 514(1):1-4. PubMed ID: 2113409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of thyroid hormones in vitro and in vivo on hypothalamic neurotensin release and content.
    Sheppard MC; Shennan KI
    Endocrinology; 1983 Jun; 112(6):1996-8. PubMed ID: 6406207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A TRH analog (DN-1417). Effects on the levels of monoamines and the metabolites in the various brain regions in rats].
    Nagai Y; Narumi S; Miyamoto M; Shima T; Saji Y; Nagawa Y
    Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):209-20. PubMed ID: 3924795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin-induced hypothermia: evidence for an interaction with dopaminergic systems and the hypothalamic--pituitary--thyroid axis.
    Nemeroff CB; Bissette G; Manberg PJ; Osbahr AJ; Breese GR; Prange AJ
    Brain Res; 1980 Aug; 195(1):69-84. PubMed ID: 6446951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.